Construction of a plasmid containing human SMN, the SMA determining gene, coupled to EGFP

Plasmid

Volumn 47, Issue 2, 2002, Pages 79-87

  Arnold, Anne Sophie ^a   Gueye, Mor ^a   Rondé, Philippe ^b   Warter, Jean Marie ^a   Poindron, Philippe ^a   Gies, Jean Pierre ^a  

^a Laboratoire De Pathologie Des Communications Entre Cellules Nerveuses Et Musculaires   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

pEGFP C3; Primary human muscle cells; Spinal muscular atrophy (SMA); Survival motor neuron (SMN)

Indexed keywords

COMPLEMENTARY DNA; ENHANCED GREEN FLUORESCENT PROTEIN; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; DNA SEQUENCE; ESCHERICHIA COLI; FLUORESCENCE ANALYSIS; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOTONEURON; MUSCLE CELL; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN LOCALIZATION; RECOMBINANT PLASMID; SPINAL MUSCULAR ATROPHY;

EID: 0036261163     PISSN: 0147619X     EISSN: None     Source Type: Journal    
DOI: 10.1006/plas.2002.1564     Document Type: Article

References (29)

1. Transfection of human myoblasts in primary culture using cationic lipids and a polycation
2. New program for investigating adult human skeletal muscle grown aneurally in tissue culture
3. Constitutive muscular abnormalities in culture in spinal muscular atrophy
4. Degeneration of cocultures of SMA muscle cells and rat spinal cord is not due to secreted factors and cannot be prevented by neurotrophins
5. The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy
6. Green fluorescent protein as a marker for gene expression
7. Deletion of murine exon 7 directed to skeletal muscle leads to severe muscular dystrophy
8. The survival motor neuron protein in spinal muscular atrophy
9. FACS-optimized mutants of the green fluorescent protein (GFP)
10. The SMN-SIP-I complex has an essential role in spliceosomal snRNP biosynthesis
11. Muscle could be the therapeutic target in SMA treatment
12. Coilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy protein
13. Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: An animal model for spinal muscular atrophy type III
14. Identification and characterization of a spinal muscular atrophy-determining-gene
15. Correlation between severity and SMN protein level in spinal muscular atrophy
16. A mouse model for spinal muscular atrophy
17. A novel nuclear structure containing the survival of motor neurons protein
18. The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP-I are in complex with spiceosomal snRNP proteins
19. -/- mice and results in a mouse with spinal muscular atrophy
20. International SMA consortium meeting
21. Classification of spinal muscular atrophies
22. A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing
23. The survival of motor neuron (SMN) protein interacts with the snoRNP proteins fibrillarin and GAR1
24. GFP associates with microfilaments in fixed cells
25. Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos
26. SMN tudor domain structure and its interaction with the Sm proteins
27. Macromolecular complexes: SMN - The master assembler
28. Differential subcellular localization of the Survival Motor Neuron protein in spinal cord and skeletal muscle
29. The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells